$10 Billion Deal, page-10572

Recapping....

Further HIV Trial results in 2023 for BIT.
What they are claiming, immune restoration is still very significant.

Not happy with the CR at this point ... but they still have something.
They have funds again.
There has been too many trials over almost 2 decades to indicate otherwise.
That is how i still see.

It is also very significant that they can target the virus inside the cell.
Vaccines don't do that.

So it is still a complimentary drug and treatment with multiple indications and benefits.
It is also proven as safe.
The toxicology trials to dose humans completed long ago.

I think most SH are running on deep faith.
But...advances/improvements in the measurement of viral load also changed the way to assess
BIT225.
It's not really deep faith at all.
Now , it's just the process being followed and the result.

GLA SH